B. Pitt, W. Remme, F. Zannad, J. Neaton, F. Martinez et al., Eplerenone, a 12 selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial 13 infarction, N Engl J Med, vol.348, issue.14, pp.1309-1330, 2003.

W. Iraqi, P. Rossignol, M. Angioi, R. Fay, J. Nuee et al., Extracellular 15 cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left 16 ventricular dysfunction and heart failure: insights from the Eplerenone Post, p.17

, Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study. Circulation, vol.1, issue.18, pp.2471-2480, 2009.

B. Lopez, A. Gonzalez, S. Ravassa, J. Beaumont, M. U. Moreno et al.,

, Circulating Biomarkers of Myocardial Fibrosis: The Need for a Reappraisal, J Am Coll Cardiol, vol.4, issue.22, pp.2449-56, 2015.

R. Querejeta, B. López, A. González, E. Sánchez, M. Larman et al.,

, Increased collagen type I synthesis in patients with heart failure of hypertensive origin: 7 relation to myocardial fibrosis, Circulation, vol.110, issue.10, pp.1263-1271, 2004.

A. Lomeo and A. Bolner, Stability of several biochemical markers of bone metabolism, Clin 9 Chem, vol.46, issue.8, pp.1200-1202, 2000.